No Data
Hims & Hers Health Options Spot-On: On December 10th, 88,818 Contracts Were Traded, With 573.71K Open Interest
CCORF Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $38
Hims & Hers Health: Buy Rating Backed by Promising Growth in GLP-1 Market and Strong Telehealth Positioning
10 Health Care Stocks Whale Activity In Today's Session
Hims & Hers Health Options Spot-On: On December 3rd, 64,567 Contracts Were Traded, With 531.51K Open Interest
Hims & Hers Named to Inc.'s 2024 Best in Business List in Health Products Category
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
sugerine : just curious what makes you say so?
RocketX : please respect your fortune teller!
Bitcoin 100k OP : Glad u ask. understand their business, once ure a customer patient u will b a long term user because they customised medication. just look at their yearly new subscribers and the yearly revenue its a rocket numbers and u wana hav this business.
the only reason why $Palantir (PLTR.US)$ can rocket high is because alot of media coverage and inclusion in SnP500. Im waiting for this to happend to $Hims & Hers Health (HIMS.US)$ . Fair valuation shld b 50-60.
sugerine : thank you so much!